Kristina E. Krivoshapova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristina E. Krivoshapova has a total of 72 co-authors. Here are the top co-authors by number of shared publications:
- Ol'Ga Leonidovna Barbarash
Federal State Budgetary Scientific Institution “Research Institute for Complex Issues of Cardiovascular Diseases”, Academician L.S. Barbarash Boulevard, 6, Kemerovo 650002, Russia
29 shared publications - Daria Pavlovna Tsygankova
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
19 shared publications - Evgeny Dmitrievich Bazdyrev
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
19 shared publications - Anastasiya G. Neeshpapa
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo 650002, Russia
11 shared publications - Victoria N. Karetnikova
Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, Russia
11 shared publications - Aleksandr N. Kokov
Federal State Budgetary Institution Research Institute for Complex Issues of Cardiovascular Diseases, 6, boulevard named after academician L.S. Barbarasha, Kemerovo 650002, Russia
9 shared publications
Latest Publications
- Open Access
- 31 October 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (5) , 6-18
RESPIRATORY SARCOPENIA IN ELDERLY PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
Highlights Impairments in muscle status (sarcopenia and/or respiratory muscle weakness) were identified in 26,3% of elderly patients with stable ischemic heart disease. Among all patients with muscle status abnormalities, generalized sarcopenia was the most common (37.2%). Respiratory sarcopenia–defined as a combination of generalized sarcopenia and respiratory muscle weakness–occurred half as frequently, in 18.1% of cases. Notably, nearly half of the patients (44.7%) exhibited isolated respiratory muscle weakness without confirmed generalized sarcopenia. Aim. To assess the prevalence of respiratory sarcopenia (RS) in elderly patients with stable ischemic heart disease (IHD). Methods. The study included 358 elderly patients with ischemic heart disease; the median age was 65 (60; 69) years. Respiratory muscle strength was assessed in all participants by measuring maximal expiratory (MEP) and inspiratory (MIP) mouth pressures. Sarcopenia was diagnosed according to the EWGSOP (2019) criteria. Respiratory sarcopenia (RS) was diagnosed in patients presenting with a combination of reduced respiratory muscle strength and sarcopenia. Results. An assessment of muscle status revealed generalized sarcopenia in 35 patients (9.8%) and respiratory sarcopenia (RS) in 17 patients (4.8%); isolated respiratory muscle weakness was found in 42 patients (11.7%), while the majority of patients (264; 73.7%) showed no abnormalities in muscle status. Reduced respiratory muscle strength was detected in 16.5% of patients; among this subgroup, 28.8% presented with RS, and 71.2% with isolated respiratory muscle weakness. These abnormalities most frequently manifested as a combined reduction in MIP and MEP (8.1%), and less frequently as an isolated reduction in MIP (7.3%) or MEP (1.1%). The median MEP value was 1.2 times higher than the median MIP value. Correlation analysis revealed associations between respiratory muscle strength parameters and various clinical and instrumental data (age, body mass index, height, handgrip strength, muscle area, and skeletal muscle index). Conclusion. Impairments in muscle status were identified in more than one out of every four of elderly patients with ischemic heart disease. Generalized sarcopenia was confirmed in 37.2% of these patients, whereas respiratory sarcopenia was found half as frequently (18.1%). Respiratory muscle strength was preserved in the majority of patients (83.5%); however, a decline was observed in one in six (16.5%), most commonly manifesting as combined inspiratory and expiratory muscle dysfunction, with expiratory strength exceeding inspiratory strength by a factor of 1.2. Nearly half of the muscle status abnormalities (44.7%) consisted of isolated respiratory muscle weakness.
- 31 October 2026
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 15 (5) , 6-18
Open AccessRESPIRATORY SARCOPENIA IN ELDERLY PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
Highlights Impairments in muscle status (sarcopenia and/or respiratory muscle weakness) were identified in 26,3% of elderly patients with stable ischemic heart disease. Among all patients with muscle status abnormalities, generalized sarcopenia was the most common (37.2%). Respiratory sarcopenia–defined as a combination of generalized sarcopenia and respiratory muscle weakness–occurred half as frequently, in 18.1% of cases. Notably, nearly half of the patients (44.7%) exhibited isolated respiratory muscle weakness without confirmed generalized sarcopenia. Aim. To assess the prevalence of respiratory sarcopenia (RS) in elderly patients with stable ischemic heart disease (IHD). Methods. The study included 358 elderly patients with ischemic heart disease; the median age was 65 (60; 69) years. Respiratory muscle strength was assessed in all participants by measuring maximal expiratory (MEP) and inspiratory (MIP) mouth pressures. Sarcopenia was diagnosed according to the EWGSOP (2019) criteria. Respiratory sarcopenia (RS) was diagnosed in patients presenting with a combination of reduced respiratory muscle strength and sarcopenia. Results. An assessment of muscle status revealed generalized sarcopenia in 35 patients (9.8%) and respiratory sarcopenia (RS) in 17 patients (4.8%); isolated respiratory muscle weakness was found in 42 patients (11.7%), while the majority of patients (264; 73.7%) showed no abnormalities in muscle status. Reduced respiratory muscle strength was detected in 16.5% of patients; among this subgroup, 28.8% presented with RS, and 71.2% with isolated respiratory muscle weakness. These abnormalities most frequently manifested as a combined reduction in MIP and MEP (8.1%), and less frequently as an isolated reduction in MIP (7.3%) or MEP (1.1%). The median MEP value was 1.2 times higher than the median MIP value. Correlation analysis revealed associations between respiratory muscle strength parameters and various clinical and instrumental data (age, body mass index, height, handgrip strength, muscle area, and skeletal muscle index). Conclusion. Impairments in muscle status were identified in more than one out of every four of elderly patients with ischemic heart disease. Generalized sarcopenia was confirmed in 37.2% of these patients, whereas respiratory sarcopenia was found half as frequently (18.1%). Respiratory muscle strength was preserved in the majority of patients (83.5%); however, a decline was observed in one in six (16.5%), most commonly manifesting as combined inspiratory and expiratory muscle dysfunction, with expiratory strength exceeding inspiratory strength by a factor of 1.2. Nearly half of the muscle status abnormalities (44.7%) consisted of isolated respiratory muscle weakness.
- Open Access
- 4 October 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (9) , 6820
Muscle status in patients with coronary artery disease and heart failure with preserved ejection fraction
Aim. To evaluate the relationship between muscle status (MS) phenotypes (sarcopenia, dynapenia) and myocardial remodeling parameters and clinical characteristics in patients with stable coronary artery disease and heart failure with preserved ejection fraction (HFpEF). Material and methods . The study included patients with HFpEF of ischemic origin who underwent a clinical and paraclinical examination. Standard clinical and biochemical laboratory parameters, structural and functional cardiac parameters were assessed (echocardiography), and MS impairments were diagnosed (muscle strength, mass, and function determination). Sarcopenia and dynapenia were defined according to international criteria. Comparative, regression, and receiver operating characteristic analyses were conducted to identify independent predictors of impaired MS. Results. The proportion of women in the sarcopenia and dynapenia groups was higher than in the normal MS group (p=0,044). Sarcopenia was associated with lower values of left ventricular end-diastolic and systolic volumes, stroke volume, and left atrial volume (pConclusion. The phenotypes of aberrant MS in HFpEF are clinically and structurally heterogeneous. The obtained data emphasize the need for a comprehensive assessment of MS in this population.
- 4 October 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 31 (9) , 6820
Open AccessMuscle status in patients with coronary artery disease and heart failure with preserved ejection fraction
Aim. To evaluate the relationship between muscle status (MS) phenotypes (sarcopenia, dynapenia) and myocardial remodeling parameters and clinical characteristics in patients with stable coronary artery disease and heart failure with preserved ejection fraction (HFpEF). Material and methods . The study included patients with HFpEF of ischemic origin who underwent a clinical and paraclinical examination. Standard clinical and biochemical laboratory parameters, structural and functional cardiac parameters were assessed (echocardiography), and MS impairments were diagnosed (muscle strength, mass, and function determination). Sarcopenia and dynapenia were defined according to international criteria. Comparative, regression, and receiver operating characteristic analyses were conducted to identify independent predictors of impaired MS. Results. The proportion of women in the sarcopenia and dynapenia groups was higher than in the normal MS group (p=0,044). Sarcopenia was associated with lower values of left ventricular end-diastolic and systolic volumes, stroke volume, and left atrial volume (pConclusion. The phenotypes of aberrant MS in HFpEF are clinically and structurally heterogeneous. The obtained data emphasize the need for a comprehensive assessment of MS in this population.
- Open Access
- 2 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (11) , 1707
Frailty Syndrome and Depressive Symptoms in Patients with Ischemic Heart Disease
Background/Objectives: This study aims to evaluate the association between frailty syndrome and depressive symptoms within a cohort of patients with ischemic heart disease (IHD). Methods: This single-center cross-sectional study included 169 patients with IHD admitted for elective percutaneous coronary intervention. The median age was 68.00 [63.00–73.00] years; 59.7% of the patients were male. Frailty screening was performed using the European PRISMA-7 questionnaire, where a score of 3 or higher indicated a high probability of frailty. Depressive symptoms were assessed using the 15-item Geriatric Depression Scale (GDS-15). The total GDS-15 score was interpreted as follows: 0–5 points indicated no depressive symptoms, 6–10 points indicated mild depression, and 11–15 points indicated severe depression. Results: The prevalence of frailty in the study cohort, based on the PRISMA-7 questionnaire, was 52.7%. The Geriatric Depression Scale (GDS-15) indicated a high probability of depressive symptoms in 19.5% of patients with IHD. The prevalence of depressive symptoms was significantly higher in frail than in non-frail patients. Furthermore, depressive disorders were 2.913 times more frequent among elderly frail patients with IHD compared to non-frail patients (95% CI: 1.262–6.725; p = 0.010). Correlation analysis confirmed a direct positive relationship between PRISMA-7 scores and GDS-15 scores (ρ = 0.392; p < 0.001). Conclusions: A significant association was identified between frailty and depressive symptoms in patients with IHD.
- 2 June 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (11) , 1707
Open AccessFrailty Syndrome and Depressive Symptoms in Patients with Ischemic Heart Disease
Background/Objectives: This study aims to evaluate the association between frailty syndrome and depressive symptoms within a cohort of patients with ischemic heart disease (IHD). Methods: This single-center cross-sectional study included 169 patients with IHD admitted for elective percutaneous coronary intervention. The median age was 68.00 [63.00–73.00] years; 59.7% of the patients were male. Frailty screening was performed using the European PRISMA-7 questionnaire, where a score of 3 or higher indicated a high probability of frailty. Depressive symptoms were assessed using the 15-item Geriatric Depression Scale (GDS-15). The total GDS-15 score was interpreted as follows: 0–5 points indicated no depressive symptoms, 6–10 points indicated mild depression, and 11–15 points indicated severe depression. Results: The prevalence of frailty in the study cohort, based on the PRISMA-7 questionnaire, was 52.7%. The Geriatric Depression Scale (GDS-15) indicated a high probability of depressive symptoms in 19.5% of patients with IHD. The prevalence of depressive symptoms was significantly higher in frail than in non-frail patients. Furthermore, depressive disorders were 2.913 times more frequent among elderly frail patients with IHD compared to non-frail patients (95% CI: 1.262–6.725; p = 0.010). Correlation analysis confirmed a direct positive relationship between PRISMA-7 scores and GDS-15 scores (ρ = 0.392; p < 0.001). Conclusions: A significant association was identified between frailty and depressive symptoms in patients with IHD.
- Open Access
- 29 April 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (3) , 4569
Association of frailty with adipokine levels in patients with stable coronary artery disease
Aim. To study the associations between the severity of frailty manifestations and serum adipokine levels in patients with coronary artery disease (CAD) before percutaneous coronary intervention (PCI). Material and methods. This single-center cohort study included 174 patients with CAD admitted to hospital for elective PCI. The mean age of patients in the study sample was 67,38±8,31 years (men, 61,5%). The "Age Is Not a Barrier" questionnaire was used to screen for pre-frailty and frailty (1-2 — no frailty, 3-4 — pre-frailty, ≥5 — frailty). A highly sensitive and highly specific enzyme-linked immunosorbent assay (ELISA) was used to determine the concentration of serum biological markers of adipose tissue remodeling. The following kits were used: AssayMax Human Adiponectin (ACRP30) ELISA Kit (USA), Diagnostics Biochem Canada Inc. Leptin ELISA Kit (London, Ontario, Canada), BioVendor R&D Human Resistin ELISA Kit (Czech Republic), and BioVendor R&D Human Chemerin ELISA Kit (Czech Republic). Results. The incidence of pre-frailty among patients with CAD based on the "Age Is Not a Barrier" scores was 38,0%, and that of frailty was 8,6%. Moreover, "frail" patients before elective PCI were significantly more often older women. Correlation analysis revealed significant associations between the "Age Is Not a Barrier" scores and the serum concentrations of chemerin (ρ=0,283, p=0,030), leptin (ρ=0,289, p=0,017), resistin (ρ=0,235, p=0,043), and adiponectin (ρ=-0,338, p=0,039), as well as age (ρ=0,200, p=0,008). Binary logistic regression confirmed a significant association between the frailty according to the "Age is not a barrier" questionnaire and lower serum adiponectin levels in patients with stable CAD (AUC=0,766; 95% confidence interval: 0,643-0,889, p=0,013) among all the predictors examined in the study. Conclusion. Significant associations were found between the severity of frailty manifestations and serum adipokine concentrations in patients with CAD before elective PCI.
- 29 April 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (3) , 4569
Open AccessAssociation of frailty with adipokine levels in patients with stable coronary artery disease
Aim. To study the associations between the severity of frailty manifestations and serum adipokine levels in patients with coronary artery disease (CAD) before percutaneous coronary intervention (PCI). Material and methods. This single-center cohort study included 174 patients with CAD admitted to hospital for elective PCI. The mean age of patients in the study sample was 67,38±8,31 years (men, 61,5%). The "Age Is Not a Barrier" questionnaire was used to screen for pre-frailty and frailty (1-2 — no frailty, 3-4 — pre-frailty, ≥5 — frailty). A highly sensitive and highly specific enzyme-linked immunosorbent assay (ELISA) was used to determine the concentration of serum biological markers of adipose tissue remodeling. The following kits were used: AssayMax Human Adiponectin (ACRP30) ELISA Kit (USA), Diagnostics Biochem Canada Inc. Leptin ELISA Kit (London, Ontario, Canada), BioVendor R&D Human Resistin ELISA Kit (Czech Republic), and BioVendor R&D Human Chemerin ELISA Kit (Czech Republic). Results. The incidence of pre-frailty among patients with CAD based on the "Age Is Not a Barrier" scores was 38,0%, and that of frailty was 8,6%. Moreover, "frail" patients before elective PCI were significantly more often older women. Correlation analysis revealed significant associations between the "Age Is Not a Barrier" scores and the serum concentrations of chemerin (ρ=0,283, p=0,030), leptin (ρ=0,289, p=0,017), resistin (ρ=0,235, p=0,043), and adiponectin (ρ=-0,338, p=0,039), as well as age (ρ=0,200, p=0,008). Binary logistic regression confirmed a significant association between the frailty according to the "Age is not a barrier" questionnaire and lower serum adiponectin levels in patients with stable CAD (AUC=0,766; 95% confidence interval: 0,643-0,889, p=0,013) among all the predictors examined in the study. Conclusion. Significant associations were found between the severity of frailty manifestations and serum adipokine concentrations in patients with CAD before elective PCI.
- Open Access
- 18 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (12) , 6258
Musculoskeletal disorders in patients with stable coronary artery disease
Aim . To determine the prevalence of aberrant musculoskeletal status (MSS) variants among patients with stable coronary artery disease (CAD) and to evaluate their paraclinical characteristics. Material and methods . Clinical and paraclinical from 160 patients with stable CAD treated at the Kemerovo Research Institute for Complex Issues of Cardiovascular Diseases were analyzed. The mean age of patients was 67 years (62,5; 73). The most common comorbidities included hypertension (n=152 (95%)), diabetes mellitus (n=46 (28,7%)), heart failure (n=160, (100%)), and chronic kidney disease (n=111 (69,4%)). Sarcopenia was verified according to the consensus of the European Working Group on Sarcopenia in Older People 2 (2019). The basis for establishing such pathology as osteoporosis and osteopenia were the t-test values in accordance with the current federal clinical guidelines. In the case of a combination of osteoporosis/osteopenia and sarcopenia, the condition was assessed as osteosarcopenia. R e sults . Patients with intact MSS were predominantly men; the group with aberrant MSS was predominantly women, which, naturally, was accompanied by shorter height, weight, and body mass index. No differences in the prevalence of comorbidities were observed. Paraclinical investigations revealed that patients with musculoskeletal system abnormalities had lower hemoglobin levels, activated partial thromboplastin time, and international normalized ratio, higher platelet counts, and lower dynamometry, musculoskeletal index, and femoral neck t-score values. Conclusion . Aberrant MSS is a fairly common pathology in patients with CAD, occurring in more than half of cases. Osteopenia is the most common pathology (68,8%), equally distributed among men and women. Osteoporosis and osteosarcopenia are observed in 13,3% and 16,8% of cases, respectively. Accordingly, isolated sarcopenia occurs in only 1,1%. MSS pathology is associated with older age, female sex (except for osteopenia), and lower height and weight.
- 18 January 2026
- Published by Silicea - Poligraf, LLC in Russian Journal of Cardiology
- Vol. 30 (12) , 6258
Open AccessMusculoskeletal disorders in patients with stable coronary artery disease
Aim . To determine the prevalence of aberrant musculoskeletal status (MSS) variants among patients with stable coronary artery disease (CAD) and to evaluate their paraclinical characteristics. Material and methods . Clinical and paraclinical from 160 patients with stable CAD treated at the Kemerovo Research Institute for Complex Issues of Cardiovascular Diseases were analyzed. The mean age of patients was 67 years (62,5; 73). The most common comorbidities included hypertension (n=152 (95%)), diabetes mellitus (n=46 (28,7%)), heart failure (n=160, (100%)), and chronic kidney disease (n=111 (69,4%)). Sarcopenia was verified according to the consensus of the European Working Group on Sarcopenia in Older People 2 (2019). The basis for establishing such pathology as osteoporosis and osteopenia were the t-test values in accordance with the current federal clinical guidelines. In the case of a combination of osteoporosis/osteopenia and sarcopenia, the condition was assessed as osteosarcopenia. R e sults . Patients with intact MSS were predominantly men; the group with aberrant MSS was predominantly women, which, naturally, was accompanied by shorter height, weight, and body mass index. No differences in the prevalence of comorbidities were observed. Paraclinical investigations revealed that patients with musculoskeletal system abnormalities had lower hemoglobin levels, activated partial thromboplastin time, and international normalized ratio, higher platelet counts, and lower dynamometry, musculoskeletal index, and femoral neck t-score values. Conclusion . Aberrant MSS is a fairly common pathology in patients with CAD, occurring in more than half of cases. Osteopenia is the most common pathology (68,8%), equally distributed among men and women. Osteoporosis and osteosarcopenia are observed in 13,3% and 16,8% of cases, respectively. Accordingly, isolated sarcopenia occurs in only 1,1%. MSS pathology is associated with older age, female sex (except for osteopenia), and lower height and weight.
- Open Access
- 13 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 255
Association Between Frailty and Leptin Levels in Patients with Stable Coronary Artery Disease
Background/Objectives: The study aimed to examine the association between the total SPPB score and serum leptin levels in patients with coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods: A cross-sectional study included 204 prospectively enrolled patients with CAD who were admitted for elective PCI. The mean age was 67.45 ± 8.63 years; 63.2% of patients were male. The Short Physical Performance Battery (SPPB) was used to screen for prefrailty and frailty (10–12 points: no frailty; 8–9 points: prefrailty; ≤7 points: frailty). The levels of leptin, a biomarker of fat remodeling, were measured by a highly sensitive and highly specific enzyme immunoassay using a Diagnostics Biochem Canada Inc. Leptin ELISA Kit (London, ON, Canada). Results: The prevalence of frailty and prefrailty in patients with stable CAD was 20.1% and 40.2%, respectively. A comparative analysis revealed that frailty was significantly more likely in older women with CAD before elective PCI. The total serum leptin level was 13.00 [8.00–50.00] ng/mL. Frail patients with CAD had higher leptin levels than patients without frailty (25.40 [7.00–60.00] ng/mL vs. 12.00 [5.15–19.70] ng/mL, p = 0.037). The leptin level in patients with prefrailty was 16.70 [13.00–49.10] ng/mL. Moreover, there was a moderate inverse correlation between the total SPPB score and serum leptin levels before PCI (p = 0.006). A regression analysis found that the total SPPB score in patients with stable CAD was associated with high serum leptin levels (p < 0.001) and older age (p = 0.017). Conclusions: Our study found that frail patients with CAD undergoing PCI had higher serum leptin levels than patients without frailty.
- 13 January 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (2) , 255
Open AccessAssociation Between Frailty and Leptin Levels in Patients with Stable Coronary Artery Disease
Background/Objectives: The study aimed to examine the association between the total SPPB score and serum leptin levels in patients with coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods: A cross-sectional study included 204 prospectively enrolled patients with CAD who were admitted for elective PCI. The mean age was 67.45 ± 8.63 years; 63.2% of patients were male. The Short Physical Performance Battery (SPPB) was used to screen for prefrailty and frailty (10–12 points: no frailty; 8–9 points: prefrailty; ≤7 points: frailty). The levels of leptin, a biomarker of fat remodeling, were measured by a highly sensitive and highly specific enzyme immunoassay using a Diagnostics Biochem Canada Inc. Leptin ELISA Kit (London, ON, Canada). Results: The prevalence of frailty and prefrailty in patients with stable CAD was 20.1% and 40.2%, respectively. A comparative analysis revealed that frailty was significantly more likely in older women with CAD before elective PCI. The total serum leptin level was 13.00 [8.00–50.00] ng/mL. Frail patients with CAD had higher leptin levels than patients without frailty (25.40 [7.00–60.00] ng/mL vs. 12.00 [5.15–19.70] ng/mL, p = 0.037). The leptin level in patients with prefrailty was 16.70 [13.00–49.10] ng/mL. Moreover, there was a moderate inverse correlation between the total SPPB score and serum leptin levels before PCI (p = 0.006). A regression analysis found that the total SPPB score in patients with stable CAD was associated with high serum leptin levels (p < 0.001) and older age (p = 0.017). Conclusions: Our study found that frail patients with CAD undergoing PCI had higher serum leptin levels than patients without frailty.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
ASSOCIATION BETWEEN FRAILTY AND VITAMIN D LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE
Highlights In the era of rapid population aging, frailty has become one of the most significant public health concerns because of the increased risk of adverse outcomes, such as functional decline, greater medical resource utilization, and higher mortality rates. Deficiency of total vitamin D (25-OH) is a common condition that may be one of the potential modifiable risk factors for the development of frailty among the elderly population. Aim. The work aimed to examine the association between the severity of frailty and serum total vitamin D (25-OH) levels in patients with coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods. A single-center cohort study included 174 patients with CAD who were admitted for elective PCI. The mean age was 67.38 ± 8.31 years; 61.5% patients were male. The Age No Hindrance questionnaire was used to screen for prefrailty and frailty (≤ 2 points: no frailty, 3–4 points: prefrailty, 5–7 points: frailty). Total vitamin D (25-OH) levels were assessed by enzyme immunoassay. Results. The incidence of prefrailty and frailty in patients with CAD according to Age No Hindrance scores was 38.0% (n = 66) and 8.6% (n = 15) respectively. Given the low incidence of frailty in the study sample, patients with prefrailty and frailty comprised a single group (46.6%, n = 81). Frailty was significantly more likely in older women with CAD before elective PCI. Frailty in patients with CAD was associated with significantly lower serum total vitamin D (25-OH) levels compared to non-frail patients (20.02 ± 7.36 (17.53–22.51) ng/mL vs. 23.91 ± 8.92 (21.02–26.81) ng/mL, р = 0.044). A correlation analysis revealed a moderate association between Age No Hindrance scores and serum total vitamin D (25-OH) levels in (mainly female) patients with stable CAD (ρ = –0.390, p = 0.024). Conclusions. The study revealed significant associations between the severity of frailty according to Age No Hindrance scores and serum total vitamin D (25-OH) levels in patients with CAD before elective PCI.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
ASSOCIATION BETWEEN FRAILTY AND VITAMIN D LEVELS IN PATIENTS WITH CORONARY ARTERY DISEASE
Highlights In the era of rapid population aging, frailty has become one of the most significant public health concerns because of the increased risk of adverse outcomes, such as functional decline, greater medical resource utilization, and higher mortality rates. Deficiency of total vitamin D (25-OH) is a common condition that may be one of the potential modifiable risk factors for the development of frailty among the elderly population. Aim. The work aimed to examine the association between the severity of frailty and serum total vitamin D (25-OH) levels in patients with coronary artery disease (CAD) undergoing elective percutaneous coronary intervention (PCI). Methods. A single-center cohort study included 174 patients with CAD who were admitted for elective PCI. The mean age was 67.38 ± 8.31 years; 61.5% patients were male. The Age No Hindrance questionnaire was used to screen for prefrailty and frailty (≤ 2 points: no frailty, 3–4 points: prefrailty, 5–7 points: frailty). Total vitamin D (25-OH) levels were assessed by enzyme immunoassay. Results. The incidence of prefrailty and frailty in patients with CAD according to Age No Hindrance scores was 38.0% (n = 66) and 8.6% (n = 15) respectively. Given the low incidence of frailty in the study sample, patients with prefrailty and frailty comprised a single group (46.6%, n = 81). Frailty was significantly more likely in older women with CAD before elective PCI. Frailty in patients with CAD was associated with significantly lower serum total vitamin D (25-OH) levels compared to non-frail patients (20.02 ± 7.36 (17.53–22.51) ng/mL vs. 23.91 ± 8.92 (21.02–26.81) ng/mL, р = 0.044). A correlation analysis revealed a moderate association between Age No Hindrance scores and serum total vitamin D (25-OH) levels in (mainly female) patients with stable CAD (ρ = –0.390, p = 0.024). Conclusions. The study revealed significant associations between the severity of frailty according to Age No Hindrance scores and serum total vitamin D (25-OH) levels in patients with CAD before elective PCI.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
VARIOUS BODY COMPOSITION DISORDERS IN ELDERLY PATIENTS WITH ATHEROSCLEROSIS OF VASCULAR BEDS
Highlights One third of elderly patients with coronary atherosclerosis have adverse musculoskeletal and fat profile. The most common type of disorder affecting muscle, fat and bone tissues includes an isolated osteopenia or sarcopenia, and less often a combination of disorders such as osteosarcopenia, sarcopenic and osteosarcopenic obesity. Aim . To identify variants of body composition disorders (BCD) affecting muscle, fat and bone tissues in elderly patients with atherosclerosis of vascular beds. Methods . The single-center cohort study included 720 patients with coronary artery disease. The inclusion criteria were: age 60 years and older with coronary atherosclerosis, selected for surgical myocardial revascularization. Among the variants of musculoskeletal and fat status disorders, osteopenic syndrome (osteopenia/osteoporosis), sarcopenia, osteosarcopenia, sarcopenic and osteosarcopenic obesity have been verified. Results . The mean age of the patients was 68.7 (64.0; 74.0) years, males were the majority (67.1%). The average score on the SARC-F questionnaire did not differ significantly in the groups of patients with various BCD. 33.6% of patients with coronary atherosclerosis had BCD, including isolated osteopenia or osteoporosis (23.9%) and sarcopenia (3.2%), whereas combined disorders in the form of osteosarcopenia (2.9%), sarcopenic (2.1%) and osteosarcopenic obesity (1.5%) were somewhat less common. Male patients were 1.2 times more likely to not have BCD compared to female patients. The logistic regression analysis demonstrated statistical significance only in the group with the detected osteopenia. The risk of this type of disorder was associated with an increase in age (OR = 1.05, 95% CI: 1.04–1.08, p = 0.008) and a history of MI (OR = 2.4, 95% CI: 1.1–4.9, p = 0.018). At the same time, male gender was associated with a reduced risk of developing this condition (OR = 0.32, 95% CI: 0.2–0.5, p = 0.00001). Conclusion . One third of elderly patients with coronary atherosclerosis had BCD. The overwhelming majority had isolated osteopenia or osteoporosis and sarcopenia, whereas combined disorders in the form of osteosarcopenia, sarcopenic and osteosarcopenic obesity were less common. SARC-F score did not differ significantly among the groups of examined patients with various BCD, thus reducing the diagnostic value of this tool in detecting musculoskeletal disorders in cardiac patients. The factors that increase the risk of osteopenia and osteoporosis include age and prior myocardial infarction, whereas male gender reduces this probability.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
VARIOUS BODY COMPOSITION DISORDERS IN ELDERLY PATIENTS WITH ATHEROSCLEROSIS OF VASCULAR BEDS
Highlights One third of elderly patients with coronary atherosclerosis have adverse musculoskeletal and fat profile. The most common type of disorder affecting muscle, fat and bone tissues includes an isolated osteopenia or sarcopenia, and less often a combination of disorders such as osteosarcopenia, sarcopenic and osteosarcopenic obesity. Aim . To identify variants of body composition disorders (BCD) affecting muscle, fat and bone tissues in elderly patients with atherosclerosis of vascular beds. Methods . The single-center cohort study included 720 patients with coronary artery disease. The inclusion criteria were: age 60 years and older with coronary atherosclerosis, selected for surgical myocardial revascularization. Among the variants of musculoskeletal and fat status disorders, osteopenic syndrome (osteopenia/osteoporosis), sarcopenia, osteosarcopenia, sarcopenic and osteosarcopenic obesity have been verified. Results . The mean age of the patients was 68.7 (64.0; 74.0) years, males were the majority (67.1%). The average score on the SARC-F questionnaire did not differ significantly in the groups of patients with various BCD. 33.6% of patients with coronary atherosclerosis had BCD, including isolated osteopenia or osteoporosis (23.9%) and sarcopenia (3.2%), whereas combined disorders in the form of osteosarcopenia (2.9%), sarcopenic (2.1%) and osteosarcopenic obesity (1.5%) were somewhat less common. Male patients were 1.2 times more likely to not have BCD compared to female patients. The logistic regression analysis demonstrated statistical significance only in the group with the detected osteopenia. The risk of this type of disorder was associated with an increase in age (OR = 1.05, 95% CI: 1.04–1.08, p = 0.008) and a history of MI (OR = 2.4, 95% CI: 1.1–4.9, p = 0.018). At the same time, male gender was associated with a reduced risk of developing this condition (OR = 0.32, 95% CI: 0.2–0.5, p = 0.00001). Conclusion . One third of elderly patients with coronary atherosclerosis had BCD. The overwhelming majority had isolated osteopenia or osteoporosis and sarcopenia, whereas combined disorders in the form of osteosarcopenia, sarcopenic and osteosarcopenic obesity were less common. SARC-F score did not differ significantly among the groups of examined patients with various BCD, thus reducing the diagnostic value of this tool in detecting musculoskeletal disorders in cardiac patients. The factors that increase the risk of osteopenia and osteoporosis include age and prior myocardial infarction, whereas male gender reduces this probability.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
CHANGES IN INDICATORS OF FRAILTY IN PATIENTS AFTER DIRECT MYOCARDIAL REVASCULARIZATION
Highlights In the era of rapid population aging, frailty has become one of the most significant public health concerns because of the increased risk of adverse outcomes, such as functional decline, greater medical resource utilization, and higher mortality rates. In low- and middle-income countries, there is a growing need to identify and monitor the dynamics of frailty in order to develop measures to maintain a high quality of life for ageing populations. Aim. To study the changes in indicators of pre-frailty and frailty syndrome in patients within three years after primary elective coronary artery bypass grafting. Methods . The study included 387 patients with multivessel coronary artery disease before undergoing direct myocardial revascularization. Various diagnostic approaches were used to identify pre-frailty and frailty syndrome, such as a multi-stage diagnostic algorithm from the frailty recommendations of the Russian Public Organization «Russian Association of Gerontologists and Geriatricians» (2020), the «PRISMA-7» questionnaire, the criteria for the Fried frailty phenotype, and the 5-factor modified frailty index (mFI-5). Statistical processing of the results was carried out using the IBM SPSS Statistics 26.0.0 software. Results. The results of the analysis of the clinical and anamnestic characteristics of the sample revealed a classic portrait of patients with multivessel coronary artery disease, the majority of patients were men (73.1%), the median age was 65 [59; 69] years. The incidence of pre-frailty among patients with coronary artery disease ranged from 15.0 to 42.4%, and the incidence of frailty syndrome ranged from 22.5 to 71.6%. Within three years after elective coronary bypass surgery, according to several diagnostic approaches, the manifestations of pathological aging of the body can increase by an average of 5.0–10.0%, whereas using European «PRISMA-7» questionnaire revealed significant differences (p = 0.045). Conclusions . The progression of frailty in patients with coronary artery disease three years after direct myocardial revascularization varies on average from 5.0 to 10.0% according to the results of the study.
- 30 December 2025
- Published by NII KPSSZ in Complex Issues of Cardiovascular Diseases
- Vol. 14 (6S)
CHANGES IN INDICATORS OF FRAILTY IN PATIENTS AFTER DIRECT MYOCARDIAL REVASCULARIZATION
Highlights In the era of rapid population aging, frailty has become one of the most significant public health concerns because of the increased risk of adverse outcomes, such as functional decline, greater medical resource utilization, and higher mortality rates. In low- and middle-income countries, there is a growing need to identify and monitor the dynamics of frailty in order to develop measures to maintain a high quality of life for ageing populations. Aim. To study the changes in indicators of pre-frailty and frailty syndrome in patients within three years after primary elective coronary artery bypass grafting. Methods . The study included 387 patients with multivessel coronary artery disease before undergoing direct myocardial revascularization. Various diagnostic approaches were used to identify pre-frailty and frailty syndrome, such as a multi-stage diagnostic algorithm from the frailty recommendations of the Russian Public Organization «Russian Association of Gerontologists and Geriatricians» (2020), the «PRISMA-7» questionnaire, the criteria for the Fried frailty phenotype, and the 5-factor modified frailty index (mFI-5). Statistical processing of the results was carried out using the IBM SPSS Statistics 26.0.0 software. Results. The results of the analysis of the clinical and anamnestic characteristics of the sample revealed a classic portrait of patients with multivessel coronary artery disease, the majority of patients were men (73.1%), the median age was 65 [59; 69] years. The incidence of pre-frailty among patients with coronary artery disease ranged from 15.0 to 42.4%, and the incidence of frailty syndrome ranged from 22.5 to 71.6%. Within three years after elective coronary bypass surgery, according to several diagnostic approaches, the manifestations of pathological aging of the body can increase by an average of 5.0–10.0%, whereas using European «PRISMA-7» questionnaire revealed significant differences (p = 0.045). Conclusions . The progression of frailty in patients with coronary artery disease three years after direct myocardial revascularization varies on average from 5.0 to 10.0% according to the results of the study.
- Open Access
- 30 November 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (10) , 4594
Imaging methods for assessing fat depot status in osteosarcopenic obesity
Aim . To analyze the incidence of osteosarcopenic obesity (OSO) using various fat depot indices in patients with multivessel coronary artery disease. Material and methods . A total of 800 patients were included, with indices assessed after 12 months. Sarcopenia was diagnosed according to the criteria of the European Working Group on Sarcopenia in Older People (EWGSOP, 2019), and osteopenic syndrome was diagnosed according to World Health Organization (WHO, 2008) guidelines. Sarcopenia was screened using the SARC-F questionnaire, handgrip test, multislice computed tomography (CT) of muscle tissue, and dual-energy X-ray absorptiometry. Body mass index (BMI) was assessed. Bioimpedance analysis, computed tomography, and adipose tissue ultrasound were performed. Statistical significance was considered at p≤0,05. Results . A BMI >30 kg/m 2 was more common at baseline in women (50,9%) compared to men (38,6%) (p=0,002), and in the prospective phase — 59,2% and 40,0%, respectively (p=0,001). Visceral fat values based on CT were higher in men, consistent with bioimpedance analysis and ultrasound findings. Subcutaneous fat thickness in women was higher than in men. Given the CT limitations and the inability to assess the musculoskeletal component using ultrasound, bioimpedance analysis can be used as an alternative diagnostic method for OSO. Conclusion . The incidence of obesity depended on the diagnostic method and ranged from 38,7% to 81,2% in men and 31,0% to 91,2% in women. An analysis of the detection rate of visceral adipose tissue components revealed sex differences and variations in the studied indicator depending on the diagnostic method (from 2,0% for BMI to 16,4% for intraabdominal fat thickness).
- 30 November 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (10) , 4594
Open AccessImaging methods for assessing fat depot status in osteosarcopenic obesity
Aim . To analyze the incidence of osteosarcopenic obesity (OSO) using various fat depot indices in patients with multivessel coronary artery disease. Material and methods . A total of 800 patients were included, with indices assessed after 12 months. Sarcopenia was diagnosed according to the criteria of the European Working Group on Sarcopenia in Older People (EWGSOP, 2019), and osteopenic syndrome was diagnosed according to World Health Organization (WHO, 2008) guidelines. Sarcopenia was screened using the SARC-F questionnaire, handgrip test, multislice computed tomography (CT) of muscle tissue, and dual-energy X-ray absorptiometry. Body mass index (BMI) was assessed. Bioimpedance analysis, computed tomography, and adipose tissue ultrasound were performed. Statistical significance was considered at p≤0,05. Results . A BMI >30 kg/m 2 was more common at baseline in women (50,9%) compared to men (38,6%) (p=0,002), and in the prospective phase — 59,2% and 40,0%, respectively (p=0,001). Visceral fat values based on CT were higher in men, consistent with bioimpedance analysis and ultrasound findings. Subcutaneous fat thickness in women was higher than in men. Given the CT limitations and the inability to assess the musculoskeletal component using ultrasound, bioimpedance analysis can be used as an alternative diagnostic method for OSO. Conclusion . The incidence of obesity depended on the diagnostic method and ranged from 38,7% to 81,2% in men and 31,0% to 91,2% in women. An analysis of the detection rate of visceral adipose tissue components revealed sex differences and variations in the studied indicator depending on the diagnostic method (from 2,0% for BMI to 16,4% for intraabdominal fat thickness).